Skip to main content

Table 3 EOS end of study, EOF end of follow-up

From: Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19): a structured summary of a study protocol for a randomized controlled trial

Visit Basal and randomization, day 0 Day 3 ± 1 Day 12 ± 2  
V#1 V#2 V#3 EOS EOF
Informed consent X
Inclusion/exclusion criteria X
Demographic data and medical history X
Concomitant medication X
Vital signs* X X
Anthropometric data^ X
Basal laboratory X
PCR swab X X
Assessment of adverse events X X X
Final objective evaluation X X X X
Randomization X
Adherence to treatment X X
  1. *Includes heart rate, temperature, and oxygen saturation by a digital saturometer
  2. ^Includes weight and height